Approval · Notice of Compliance 37862 · 2026
JOENJA: Notice of Compliance 37862
Issued July 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37862
- Date
- July 8, 2026
- Company
- Pharming Technologies B.V.Leiden, Netherlands
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JOENJA | 02569809 | Approved |
Medicinal ingredients
- LENIOLISIB PHOSPHATE 70 MG per TAB